Literature DB >> 7774350

Interferon-related bronchiolitis obliterans organizing pneumonia.

K Ogata1, T Koga, K Yagawa.   

Abstract

We present an unusual case of a patient with chronic hepatitis C who experienced dyspnea, fever, and cough after 2 1/2 months' treatment with interferon. His radiograph demonstrated diffuse pulmonary infiltrates and bronchoalveolar lavage fluid showed an increase in lymphocytes, especially CD8-positive cells. The lung biopsy findings were bronchiolitis obliterans organizing pneumonia (BOOP). The pulmonary symptoms disappeared and the chest radiograph became normal after interferon therapy was discontinued and corticosteroid therapy was given. Interferon is suspected to be responsible for the BOOP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7774350     DOI: 10.1378/chest.106.2.612

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

2.  Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha.

Authors:  S Yamaguchi; K Kubo; K Fujimoto; T Honda; M Sekiguchi; T Sodeyama
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

3.  Managing patients on interferon therapy.

Authors:  R Esteban
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Respiratory reovirus 1/L induction of intraluminal fibrosis. A model for the study of bronchiolitis obliterans organizing pneumonia.

Authors:  S C Bellum; D Dove; R A Harley; W B Greene; M A Judson; L London; S D London
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Interferon alpha: A rare cause of persistent pulmonary hypertension of newborn.

Authors:  Hardeep Kaur; Harish Sethi; Gaurav Mahajan
Journal:  Med J Armed Forces India       Date:  2018-02-14

Review 6.  Bronchiolitis obliterans with organising pneumonia: outcome.

Authors:  U Costabel; J Guzman; H Teschler
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

7.  Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.

Authors:  Sonu Dhillon; Anshul Kaker; Aneil Dosanjh; Deepa Japra; David H Vanthiel
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

8.  Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin.

Authors:  Evaldo Stanislau Affonso de Araújo; Aleia Faustina Campos; Juliana Yamashiro; Evandro Sobrosa Mello; Teresa Takagaki; Antonio Alci Barone
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

9.  Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes.

Authors:  Elizabeth I Majeski; Manjeet K Paintlia; Andrea D Lopez; Russell A Harley; Steven D London; Lucille London
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 10.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.